CLINICAL_TRIALS
trial_result
· 2021-01-07
Clinical Trial Update: Study to Evaluate the Effect of Benralizumab on Allergen-Induced Inflammation in Mild, Atopic Asthmatics [Phase 3]
Summary
Phase 3 study evaluating benralizumab on allergen-induced inflammation in mild, atopic asthma has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: AstraZeneca | Conditions: Asthma | Phase 3 | Status: COMPLETED | Results posted: 2021-01-07